Literature DB >> 21287396

Gene expression profiles of T cells from hepatitis E virus infected patients in acute and resolving phase.

Nirupma TrehanPati1, Sukriti Sukriti, Robert Geffers, Syed Hissar, Peggy Riese, Tanja Toepfer, Carlos A Guzman, Shiv Kumar Sarin.   

Abstract

BACKGROUND AND AIMS: Approximately 50% of acute viral hepatitis in young adults and in pregnant women is due to hepatitis E virus (HEV) infection in developing countries. T cell-mediated immune injury probably plays a key role in the pathogenesis of acute hepatitis illness. However, there is a paucity of data on the global gene expression programs activated on T cells, which are subsequently responsible for T cell recruitment to the liver and triggering of immune injury. PATIENTS AND METHODS: We performed a flow cytometric analysis of T cells in individuals with acute hepatitis E (AVH-E; n=10), resolving phase of HEV (n=9), and ten healthy controls (HC). Further transcriptional profiling analysis was performed using Affymetrix GeneChip DNA microarrays to identify the genes that were differentially expressed in AVH-E and HC.
RESULTS: Patients with AVH-E showed higher frequencies of CD8+ (27 ± 4%; P=0.02) and activated CD38+ CD69+ T cells (25% ± 3%; P=0.04) than in resolving phase patients (20 ± 2% and 9.1 ± 4%, respectively), who in turn exhibited higher CCR9 expression than cells from patients in active phase. The naïve T cell population (CD3+ CD45RA+) was decreased upon HEV infection (29 ± 4% in AVH-E vs. 53.1 ± 3.2% in HC; P=0.05); however, the CD11a high subpopulation within CD4+ CD45RA+ cells was increased in both AVH-E (6.1%) and resolving phase (7.7%) patients. Gene ontology analysis suggested that during AVH-E infection, there is in CD4+ T cells an activation of genes involved in pro-inflammatory responses. Additional RT-PCR analysis confirmed that in cells from AVH-E patients, there is an increased expression of CCR5, CCR9, CXCR3, CXCR4, STAT1, IRF-9, IFN-α, and TNF-α, together with a down-regulation of IL-2, SOCS3, and IL-10, with respect to cells from resolving phase patients.
CONCLUSIONS: Our findings suggest the involvement of a circulating CD45RA+ CD11a high population with CCR5 expression in the pathogenesis processes of AVH-E. The obtained results help to understand the underlying inflammatory process occurring in HEV infection, which can lead to either resolution or immunopathology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21287396     DOI: 10.1007/s10875-010-9506-2

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  28 in total

1.  Chemokine receptors support infiltration of lymphocyte subpopulations in human hepatocellular carcinoma.

Authors:  Yuqing Liu; Ronnie T Poon; Jeremy Hughes; Xiaoqin Feng; Wan Ching Yu; Sheung Tat Fan
Journal:  Clin Immunol       Date:  2005-02       Impact factor: 3.969

Review 2.  Mechanisms of chemokine and antigen-dependent T-lymphocyte navigation.

Authors:  Stephen G Ward; Federica M Marelli-Berg
Journal:  Biochem J       Date:  2009-02-15       Impact factor: 3.857

3.  Acute liver failure in India.

Authors:  M S Khuroo
Journal:  Hepatology       Date:  1997-07       Impact factor: 17.425

Review 4.  On T cell memory: arguments for antigen dependence.

Authors:  T M Kündig; M F Bachmann; P S Ohashi; H Pircher; H Hengartner; R M Zinkernagel
Journal:  Immunol Rev       Date:  1996-04       Impact factor: 12.988

5.  Hepatitis E and long-term antibody status.

Authors:  M S Khuroo; S Kamili; M Y Dar; R Moecklii; S Jameel
Journal:  Lancet       Date:  1993-05-22       Impact factor: 79.321

6.  An epidemic of hepatitis D in the foothills of the Himalayas in south Kashmir.

Authors:  M S Khuroo; S A Zargar; R Mahajan; G Javid; R Lal
Journal:  J Hepatol       Date:  1988-10       Impact factor: 25.083

Review 7.  Hepatitis E and pregnancy: understanding the pathogenesis.

Authors:  Udayakumar Navaneethan; Mayar Al Mohajer; Mohamed T Shata
Journal:  Liver Int       Date:  2008-07-25       Impact factor: 5.828

8.  Alterations in natural killer cells and natural killer T cells during acute viral hepatitis E.

Authors:  R Srivastava; R Aggarwal; M R Bhagat; A Chowdhury; S Naik
Journal:  J Viral Hepat       Date:  2008-07-28       Impact factor: 3.728

9.  Viral load, antibody titers and recombinant open reading frame 2 protein-induced TH1/TH2 cytokines and cellular immune responses in self-limiting and fulminant hepatitis e.

Authors:  S Saravanabalaji; A S Tripathy; R R Dhoot; M S Chadha; A L Kakrani; V A Arankalle
Journal:  Intervirology       Date:  2009-04-28       Impact factor: 1.763

10.  Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection.

Authors:  Sharda Patra; Ashish Kumar; Shubha Sagar Trivedi; Manju Puri; Shiv Kumar Sarin
Journal:  Ann Intern Med       Date:  2007-07-03       Impact factor: 25.391

View more
  8 in total

1.  Hepatitis E virus quasispecies and the outcome of acute hepatitis E in solid-organ transplant patients.

Authors:  Sebastien Lhomme; Florence Abravanel; Martine Dubois; Karine Sandres-Saune; Lionel Rostaing; Nassim Kamar; Jacques Izopet
Journal:  J Virol       Date:  2012-07-03       Impact factor: 5.103

Review 2.  Hepatitis E virus infection: Epidemiology and treatment implications.

Authors:  Ga Young Lee; Kittiyod Poovorawan; Duangnapa Intharasongkroh; Pattaratida Sa-Nguanmoo; Sompong Vongpunsawad; Chintana Chirathaworn; Yong Poovorawan
Journal:  World J Virol       Date:  2015-11-12

3.  Cytokine profiles, CTL response and T cell frequencies in the peripheral blood of acute patients and individuals recovered from hepatitis E infection.

Authors:  Anuradha S Tripathy; Rumki Das; Sanjay B Rathod; Vidya A Arankalle
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

Review 4.  Clinical Manifestations, Pathogenesis and Treatment of Hepatitis E Virus Infections.

Authors:  Sébastien Lhomme; Olivier Marion; Florence Abravanel; Jacques Izopet; Nassim Kamar
Journal:  J Clin Med       Date:  2020-01-24       Impact factor: 4.241

5.  Infection by Brazilian and Dutch swine hepatitis E virus strains induces haematological changes in Macaca fascicularis.

Authors:  Lilian G de Carvalho; Renato S Marchevsky; Debora R L dos Santos; Jaqueline M de Oliveira; Vanessa S de Paula; Leilane M Lopes; Wilhelmus H M Van der Poel; Jorge E González; Maria S Munné; Julio Moran; Ana Carolina R A Cajaraville; Marcelo Pelajo-Machado; Oswaldo G Cruz; Marcelo A Pinto
Journal:  BMC Infect Dis       Date:  2013-10-23       Impact factor: 3.090

6.  Hepatitis E rORF2p stimulated and unstimulated peripheral expression profiling in patients with self-limiting hepatitis E infection.

Authors:  Sanjay B Rathod; Anuradha S Tripathy
Journal:  J Immunol Res       Date:  2014-05-15       Impact factor: 4.818

7.  Serum Levels of Soluble CD26, A Novel Prognostic Marker for Hepatitis E Infection.

Authors:  Alireza Rafiei; Abolghasem Ajami; Araz Mohammad Mirabi; Mohammad Jafar Saffar; Omolbanin Amjadi; Mohammad Reza Haghshenas; Farshideh Abedian; Pouya Khaje-Enayati
Journal:  Jundishapur J Microbiol       Date:  2016-02-15       Impact factor: 0.747

Review 8.  Hepatitis E Pathogenesis.

Authors:  Sébastien Lhomme; Olivier Marion; Florence Abravanel; Sabine Chapuy-Regaud; Nassim Kamar; Jacques Izopet
Journal:  Viruses       Date:  2016-08-05       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.